Views & Analysis Healthcare in 2030: what role for pharma? Prevention and self-management increasingly important in healthcare systems of the future.
News Amid political tumult, a new leader for Europe’s pharma indu... The European pharma industry has appointed a new leader – just as EU politicians face their greatest test in a generation
News UK science funding uncertain after Brexit vote UK government says funding will continue until Brexit is resolved.
News ADA: AZ reveals oral GLP-1 data in obesity, diabetes AstraZeneca prepares to move its oral GLP-1 elecoglipron into phase 3 for obesity and diabetes, after reporting encouraging phase 2b data at ADA.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
